Bioventix Share Price (BVXP)

Find Your Broker

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Bioventix	LSE:BVXP	London	Ordinary Share	GB00B4QVDF07	ORD 5P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	3,210.00p	741	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
3,170.00p		3,250.00p	3,210.00p	3,210.00p	3,210.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	7.98	6.87	110.21	29.1	165.0

Related Shares
AstraZeneca (AZN), GlaxoSmithKline (GSK), Venn Life (VENN), Port Erin (PEBI)

Bioventix (BVXP) Latest News

Bioventix News

Date	Time	Source	Headline
06/12/2018	15:47	UKREG	Bioventix Plc Result of AGM
06/12/2018	15:46	PRNUS	Bioventix Plc - Result of AGM
05/12/2018	14:33	UKREG	Bioventix Plc Holding(s) in Company
05/12/2018	14:33	PRNUS	Bioventix Plc - Holding(s) in Company
05/12/2018	14:24	UKREG	Bioventix Plc Holding(s) in Company
05/12/2018	14:24	PRNUS	Bioventix Plc - Holding(s) in Company
08/10/2018	11:35	ALNC	Bioventix Special Dividend Up 38% As Back Dated Royalty Boosts Profit
08/10/2018	06:23	ALNCF	Alliance News Flash Headline
08/10/2018	06:00	UKREG	Bioventix Plc Results for the year ended 30 June 2018
08/10/2018	06:00	PRNUS	Bioventix Plc - Results for the year ended 30 June 2018

More Bioventix News

Bioventix Takeover Rumours

Bioventix (BVXP) Share Charts

1 Year Bioventix Chart

1 Month Bioventix Chart

Intraday Bioventix Chart

Bioventix (BVXP) Discussions and Chat

Bioventix Forums and Chat

Date	Time	Title	Posts
03/12/2018	11:39	Bioventix - Sheep Antibodies	924
08/11/2016	13:07	ShareSoc Supper in Brighton	-

Add a New Thread

Bioventix (BVXP) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Bioventix trades in real-time

Bioventix (BVXP) Top Chat Posts

Date	Subject
16/12/2018 08:20	Bioventix Daily Update: Bioventix is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BVXP. The last closing price for Bioventix was 3,210p. Bioventix has a 4 week average price of 3,155p and a 12 week average price of 2,655p. The 1 year high share price is 3,450p while the 1 year low share price is currently 2,000p. There are currently 5,140,674 shares in issue and the average daily traded volume is 6,569 shares. The market capitalisation of Bioventix is £165,015,635.40. Read Full Thread Reply
10/9/2018 08:22	ilovefrogs: Not much growth for a stock on 32x earnings though is it? Fantastic cash generative company, but definite downside risk at this level of share price IMO. I'm still in but I'm selling a few here - be happy to buy them back at £25! We'll see. Read Full Thread Follow Reply
16/7/2018 12:57	stepone68: Yup, forecasts have been beaten every year recently, but it's not going to sit on a PE of 30 forever, so share price increases are going to be harder to come by, although fingers crossed that Finncap note turns out to be correct! Read Full Thread Follow Reply
29/3/2018 13:35	igbertsponk: Happy reading like the share price again! Read Full Thread Follow Reply
26/3/2018 09:13	whilstev: Was worried these results might disappoint after recent share price weakness but really pleased with these. Looks like we will get another special div with full year results as well with cash held continuing to rise. Will continue to hold. Read Full Thread Follow Reply
08/12/2017 20:19	soundsplausible: Anyone going to the AGM? The share price seems to be reflecting the lack of news for a wee while now and has been on a downward trend of late. (guess whose stop loss kicked in today) Read Full Thread Follow Reply
16/10/2017 13:02	walbrock82: Another good performance from Bioventix. Here is my analysis: Breakdown of results Results came in better than forecasted at £7.24m vs. £7.1m. Most of their sales come from royalty and license fee (£5.3m) with R&D and product revenue making up the rest. Pre-tax profit increased to £5.7m, compared to £4.2m giving the business a high margin in the 70s. The biggest surprise is the dividend announcement of a second interim dividend of 31p and a special dividend of 40p. Balance sheet A great balance sheet with cash making up 60% of total assets. No debt and no pension deficit. Cash Flow The balance sheet is neat with high levels of cash inflows and the only cash outflow is basically rewarding shareholders. Talking of dividends, this paid the company is paying 91p vs. 62.5p (including the special) Including the special, the yield climbs over 3%. But what impressed me the most is the 50% dividend growth helped by the special dividend increasing 100%. Is Bioventix fully-priced in? When you see revenue of £7.2m vs. the market cap. of £142m it looks pricey. And, despite EPS Growth averaging circa. 26% (which is typical of a sustainable rate for a small business) the market has raced ahead of itself. Market metrics such as: EV/EBIT = 27 times, now down to 24 times, the 6-year average is 13 times. PE = 40.7 times, now down to 29 times, the 6-year average is 19 times. PB = 17.3 times, now down to 14.1 times, the 6-year average is 7.3 times. PS = 25.8 times, now down to 19.7 times, the 6-year average is 10 times. On the flip-side: If you are a L-T investor, then you thinking five or ten years ahead. My advice is if Bioventix can sustain their business model, then we can make a hypothetical forecast. Assuming net profit grow by 20% for the next five years, then on current valuation, then PE comes to 11 times. And if the company keeps their current PE ratio of 29 times, you are looking at a share price of circa £70 per share! Things to be cautious Looking at Bioventix business and financials, I get the sense of feeling that their technology is reliance on a few talented staff (the company employs 15 people). So, staff safety and morale is paramount to Bioventix continuous success. Another is the entry of new competitors. Given the low cost of entry (all you need is the talent), then there is no guarantee of success if another business develops a superior product. Final Thoughts It reminds me of Rightmove with their high operating margin and low asset maintenance costs. Unlike Rightmove, they have vulnerabilities because the probability of staff accident can be fatal to future business success or a competitor muscling in (low cost of entry). So, in many ways they are competitive, but with a few speculative features lingering about. I think £20 per share or 21-times PE is good value. Interested in other companies’ updates and results, then click http://bit.ly/2ypK3dk Read Full Thread Follow Reply
28/9/2017 11:47	stepone68: Yes it's always been last traded price on Yahoo, which is bad enough. But 2500? When was the last trade at 2500 for BVXP? If you look at the link I put above, it still shows 2500 as the price, but the Bid/Ask are at 2700/2775. It normally updates after the markets close. So when I updated my spreadsheet about 5pm yesterday, it went to 2700. But when I refreshed it again about 10.30pm last night, suddenly it dropped to the 2500, where it has remained. Bizarre. Never mind, as long as the real share price is going up... StepOne Read Full Thread Follow Reply
28/9/2017 08:07	stepone68: MAybe a daft question, but can anyone tell me the BVXP share price? My spreadsheet pulls data from Yahoo Finance, which is showing 2500p, as is a portfolio watcher app I use. See hTTps://uk.finance.yahoo.com/quote/BVXP.L?p=BVXP.L The graph above implies 2750, as does digital look. It's not the first time Yahoo Finance has been way out - is there a reason for this? StepOne Read Full Thread Follow Reply
06/9/2017 19:42	soundsplausible: With the share price so high do you think the company might go for a share split? With the continual good news (re higher profits, huge margins, low cost base etc.) must mean Bioventix is on more people's radar. Liquidity must be a deterant, just like the daily spread and high share price. So who's for a share split being a surprise announcement when results are due? Read Full Thread Follow Reply
11/5/2017 12:21	carcosa: There is sufficient evidence to confirm that when a share price rises to the levels we are seeing with BVXP that a share-split does indeed attract new investors. It happens more frequently in America where the stock (shares in British parlance) price alone can be used as a rough and ready valuation tool against other stocks within the same sectors. Is it logical? Perhaps not. Personally I do not much like share-splits as it appears to result in more volatility which I dislike. Still, if investing was all about logic then we would not be having so much fun... Read Full Thread Follow Reply

Bioventix share price data is direct from the London Stock Exchange

Your Recent History

LSE

BVXP

Bioventix

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20181216 08:53:24